Latest Biotech News

Pfizer struck a landmark deal with the U.S. government granting it a three-year tariff exemption in exchange for commitments to enhance domestic drug manufacturing and implement "most favored...

Trogenix reported a $95 million Series A funding round aimed at bolstering its novel 'Trojan horse' therapeutic platform targeting glioblastoma, a highly aggressive form of brain cancer. This...

New research published in Nature Computational Science introduces virtual brain twins—advanced computational models replicating patient-specific neurophysiology—to precisely simulate epileptic...

Hong Kong-based biotech Regencell Bioscience Holdings experienced an extraordinary stock surge exceeding 64,000% during mid-2025 driven by retail speculation, social media hype, and a 38-for-1...

The U.S. Food and Drug Administration has initiated a pilot program aimed at expediting the regulatory review of generic drugs that are tested, manufactured, and sourced entirely within the United...

A comprehensive landscape analysis reveals a growing global pipeline of Natural Killer (NK) cell therapies for solid tumors, underscoring their emerging role in immuno-oncology. These therapies...

Dovetail Genomics' innovative LinkPrep technology enables simultaneous sequencing of DNA bases and three-dimensional genome organization, uncovering structural variants and regulatory disruptions...

New findings indicate that targeting Polo-like kinase 1 (PLK1) potentiates gemcitabine-induced apoptosis in pancreatic cancer cells, providing a synergistic therapeutic strategy. This study...

A population-based cohort study published in the Canadian Medical Association Journal identifies a significant association between traumatic brain injuries in adults over 65 and heightened...

The third quarter of 2025 saw 62 biopharma layoff rounds, closely mirroring previous quarterly figures and positioning 2025 to exceed 2024’s total workforce reductions. Major companies such as...

The U.S. Food and Drug Administration initiated a new pilot program aimed at accelerating the regulatory review of generic drugs manufactured and tested in the United States using domestically...

Regencell Bioscience Holdings, a small Hong Kong-based biotech focused on traditional Chinese medicine treatments for neurocognitive disorders, experienced an unprecedented stock surge of up to...

The biopharmaceutical sector recorded 62 layoff rounds in the third quarter of 2025, reflecting a continuation of a challenging employment environment. Major companies including Novo Nordisk,...

Medtronic in collaboration with UCSF researchers, led by Maria Shcherbakova, has developed adaptive deep brain stimulation technology that automatically adjusts brain implants in real time to...

Researchers have introduced EDG-PPIS, an equivariant and dual-scale graph network framework designed to improve prediction accuracy of protein–protein interaction sites. This advancement in...

An innovative study integrates artificial neural networks with hyperspectral imaging to enhance prognostic assessments in esophageal adenocarcinoma. This approach enables detailed analysis of...

Dovetail Genomics has introduced LinkPrep™, a technology that simultaneously reads DNA sequence and genome 3D architecture, providing insights into structural variants and regulatory disruptions...

FDA leaders from CDER and CBER are scheduled to meet with key industry groups including BIO and PhRMA to discuss the reauthorization of the Prescription Drug User Fee Act (PDUFA). These...

The Trump administration is completing the final review of a Medicare Part D rule implementing a Most Favored Nation (MFN) pricing model. This regulatory change aims to align Medicare drug prices...

New research from Mass General Brigham assesses the utility of over-the-counter continuous glucose monitors (CGMs) in individuals without diabetes and finds limited clinical benefit. While CGMs...